KalVista Investigative Site

Sapporo, Hokkaido 002-8072

0 studies enrolling now · 2 studies all time

What they study most

Hereditary Angioedema

Studies at this site

• PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial — Completed
• An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) — Completed